ELANE and acute respiratory distress syndrome: Sivelestat is a highly specific and systemically active NE inhibitor with a low molecular weight that can reversibly and competitively inhibit neutrophil elastase release, inhibit neutrophil activation and intrapulmonary inflammatory cell infiltration, alleviate the release of inflammatory mediators, thereby improving respiratory function and has a good protective effect on various experimental ALI [4–6].